OP-005 Assessment of Warfarin TTR (Time in Therapeutic Range ) Results in a tertiary Reference Center

Anticoagulant drugs (warfarin, UFH and LMWH, and direct thrombin and factor Xa inhibitors) routinely used for the prevention of thromboembolism in patients with nonvalvular AF, mechanical heart valves, deep venous thrombosis, intracavitary thrombus.

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2015-03, Vol.115, p.S2-S3
Main Authors: Tekkesin, Ahmet Ilker, Cakilli, Yasin, Turkkan, Ceyhan, Demir, Koray, Borklu, Edibe Betul, Yildirimturk, Ozlem, Cinier, Goksel, Alper, Ahmet Taha
Format: Article
Language:English
Subjects:
Anticoagulants
Cardiovascular
Drug therapy
Thrombosis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Anticoagulant drugs (warfarin, UFH and LMWH, and direct thrombin and factor Xa inhibitors) routinely used for the prevention of thromboembolism in patients with nonvalvular AF, mechanical heart valves, deep venous thrombosis, intracavitary thrombus.
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2015.01.051